ACTRN12610000125022进行中（未招募）不适用
Effects of Telmisartan on Arterial Stiffness Assessed by the Cardio-ankle Vascular Index in Hypertensive Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 20 Years 至 75 Years（—）
- 性别
- All
入选标准
- •hypertensive patients with arterial stiffness and untreated hypertension or uncontrollable hypertension treated with medications other than renin-angiotensin system (RAS) inhibitors
排除标准
- •patients with already taking RAS inhibitors
研究者
相似试验
已完成
不适用
The effect of telmisartan on endothelial function in hypertensive patients.HypertensionJPRN-UMIN000005034Seigo Sugiyama20
终止
2 期
Telmisartan in the management of abdominal aortic aneurysmAbdominal Aortic AneurysmACTRN12611000931976James Cook University208
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-BEDAIICHI SANKYO EUROPE GmbH264
进行中（未招募）
不适用
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeMedDRA version: 9.1Level: LLTClassification code 10020772Term: HypertensionEUCTR2007-003131-23-NLDAIICHI SANKYO EUROPE GmbH350
进行中（未招募）
1 期
Effect of Olmesartan Medoxomil on Arterial Stiffness and Thickness in Subjects with Metabolic SyndromeMetabolic Syndrome, HypertensionMedDRA version: 9.1 Level: LLT Classification code 10052066 Term: Metabolic syndromeMedDRA version: 9.1 Level: LLT Classification code 10020772 Term: HypertensionEUCTR2007-003131-23-GBDAIICHI SANKYO EUROPE GmbH350